contact us

PLEASE DO NOT LEAVE ANY CONFIDENTIAL TREATMENT DATA, PRIVATE PATIENT DETAILS OR ANY OTHER PROTECTED HEALTH INFORMATION (PHI) ON THIS SITE. THIS IS IN ORDER TO ENSURE PRIVACY AND REGULATORY COMPLIANCE WITH APPLICABLE PRIVACY RULES AND LAWS (INCLUDING BUT NOT LIMITED TO HIPAA).
Unsubscribe From Our Mailing List
  • BrainsWay Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update
    30 May, 2018 - ,

    BrainsWay Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update

    First quarter revenues of $3.6 million represent a quarterly record and a  68% increase over first quarter 2017 Increased market demand and leasing model continue to generate sales

    Read More
  • Achieve TMS Announces Grand Opening of New Location in Newton, Massachusetts
    23 May, 2018 - ,

    Achieve TMS Announces Grand Opening of New Location in Newton, Massachusetts

    NEWTON, Mass., May 23, 2018 (GLOBE NEWSWIRE) — Achieve TMS, the largest U.S. provider of BrainsWay’s

    Read More
  • BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
    6 May, 2018 - ,

    BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder

    The company will now have the most advanced stimulator on the market, with enhanced features that increase the ease of use for physicians and integrate a patient management

    Read More
  • Brainsway Raises $8.5 Million From Leading Israeli Investors
    12 December, 2017 - ,

    Brainsway Raises $8.5 Million From Leading Israeli Investors

    Phoenix Group becomes 7% shareholder. financing strengthens Brainsway’s balance sheet and provides strong support for continued growth HACKENSACK, N.J., Dec. 12, 2017 – Brainsway

    Read More
  • Brainsway Reports Record Quarterly Revenues in Third Quarter of 2017
    20 November, 2017 - ,

    Brainsway Reports Record Quarterly Revenues in Third Quarter of 2017

    ncreased market demand and new leasing model continue to generate significant sales growth Recently signed contracts increased total minimum revenue projection by 21% over end of second

    Read More
  • The stock in the spotlight:‎ ‎Brainsway ‎
    19 October, 2017 - ,

    The stock in the spotlight:‎ ‎Brainsway ‎

    Sponsor Editoriial Board “The transition to focusing on the leasing business model helps us continue

    Read More
  • Brainsway Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017
    23 August, 2017 - ,

    Brainsway Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017

    Backlog revenues due to future lease agreements increased 27% to $19 million Quarterly

    Read More
  • Walter Reed National Military Medical Center Acquires a Brainsway Deep TMS System to Enhance its Treatment of Depression
    23 June, 2017 - ,

    Walter Reed National Military Medical Center Acquires a Brainsway Deep TMS System to Enhance its Treatment of Depression

    Walter Reed National Military Medical Center Acquires a Brainsway® Deep TMS System to Enhance its Treatment

    Read More
  • Brainsway® Announces Positive Final Results of its Deep-TMS Multicenter Study in Obsessive Compulsive Disorder (OCD) Patients
    12 June, 2017 - ,

    Brainsway® Announces Positive Final Results of its Deep-TMS Multicenter Study in Obsessive Compulsive Disorder (OCD) Patients

    Brainsway® Announces Positive Final Results of its Deep-TMS Multicenter

    Read More
  • Brainsway Reports Strong Momentum in Q1 for 2017
    6 June, 2017 - ,

    Brainsway Reports Strong Momentum in Q1 for 2017

    Brainsway Reports Strong Momentum in Q1 for 2017 

    Read More
  • Yaacov Michlin Leads Brainsway to its Next Growth Phase and Accelerates the Mental Health Industry
    5 April, 2017 - ,

    Yaacov Michlin Leads Brainsway to its Next Growth Phase and Accelerates the Mental Health Industry

    JERUSALEM, (GLOBE NEWSWIRE) — Brainsway Ltd

    Read More
  • Brainsway Closes 2016 With 69 Percent Increase in Year-over-Year Revenue Growth
    5 April, 2017 - ,

    Brainsway Closes 2016 With 69 Percent Increase in Year-over-Year Revenue Growth

    Brainsway Closes 2016 With 69 Percent Increase in Year-over-Year Revenue Growth  Company reaches $11.5 million

    Read More
  • A Salisbury Clinic Aims To Treat Depression With New Magnetic Device
    28 March, 2017 - ,

    A Salisbury Clinic Aims To Treat Depression With New Magnetic Device

    SALISBURY, Md. – Over 350 million people worldwide suffer from depression. Community Behavioral Health in Salisbury is dedicated to helping a growing number of men and women suffering from

    Read More
  • 14 March, 2017 - ,

    Magnetic Stimulation Helmet Helping Those With Depression

    SEATTLE — For many, depression is a serious illness that seems impossible to overcome, but now there’s hope for those who have had no luck with their medication. A sophisticated helmet

    Read More
  • 23 February, 2017 - ,

    Magnetic waves used to treat depression

    SOUTH CHARLESTON, WV (WCHS/WVAH) — When medications no longer work for fighting depression, some doctors are turning to another treatment which is magnetic waves from a helmet. Every 20 seconds Patricia

    Read More
  • 15 January, 2017 - ,

    New Deep TMS Coverage for over 2 million patients!

    Brainsway is happy to announce new coverage with Excellus BC/BS, effective immediately. This decision will now provide an additional 1.55 million patients in New York with

    Read More
  • 8 January, 2017 - ,

    Deep TMS Receives Positive Results For the Treatment of Depression in Elderly Patients

    HACKENSACK, N.J., Jan. 03, 2017 (GLOBE NEWSWIRE) — 

    Read More
  • 30 November, 2016 - ,

    Brainsway Reports Continued Financial Growth for Q3 of 2016

    Revenue Increased by 87 percent to $3.4 million compared to Q3 2015 Gross profit exceeds 83 percent to approximately $2.8 million compared to Q3 2015 Third quarter Non-GAAP dilution

    Read More
  • 22 November, 2016 - ,

    Brainsway Coverage Continues to Expand: Geisinger Health Plan

    Geisinger Health Plan, offering medical coverage in Pennsylvania, recently announced that Brainsway’s depression treatment threpay will be now be covered under their insurance policies. This coverage

    Read More
  • 7 November, 2016 - ,

    Brainsway Makes Headway in European Expansion With Sale of Deep TMS System in Switzerland

    Brainsway is proud to announce that we have sold our first Deep TMS system within Switzerland. The system was purchased by a clinic focusing on depression and chronic pain management. The CE has certified

    Read More
  • 29 September, 2016 - ,

    FDA-approved helmet puts Salt Lake man’s depression into remission

    MILLCREEK — Jerid Robinett wears a helmet to keep him safe when he rides his motorcycle. He also puts one on for another life-saving purpose. “I had a really big struggle just getting

    Read More
  • 14 September, 2016 - ,

    Brainsway Attains Regulatory Approval for Marketing Deep TMS in Mexico

    JERUSALEM, Sept. 14, 2016 (GLOBE NEWSWIRE) — Brainsway

    Read More
  • 19 August, 2016 - ,

    Brainsway Reports Consistent Revenue Growth for Third Quarter in a Row and Provides Company Updates

    Q2 revenues surge by 90%, reaching $2.8M, compared to Q2 2015. Q2 gross margin surge by 94%, reaching $2.2M, compared to Q2 2015. Q2

    Read More
  • 17 August, 2016 - ,

    Jersey Shore University Medical Center is First Hospital In New Jersey to Offer Deep Transcranial Magnetic Stimulation (DTMS)

    Newswise — Neptune, N.J. – August 15, 2016 – Jersey Shore University Medical Center is the first hospital in New Jersey to offer deep transcranial magnetic stimulation (dTMS) – a non-invasive

    Read More
  • 11 August, 2016 - ,

    Brainsway Deep TMS Shows Promise for Treating Cocaine Addiction

    Two Studies in Italy Explored Deep TMS Effect on Cocaine Desire & Consumption JERUSALEM ­–

    Read More
  • 6 August, 2016 - ,

    Aetna Insurance Now Covers Transcranial Magnetic Stimulation and Cranial Electrical Stimulation

    Aetna insurance has recently expanded its coverage of transcranial magnetic stimulation for the treatment of depression. Millions of new patients now have access to this treatment! Here is the

    Read More
  • 3 August, 2016 - ,

    Deep Transcranial Magnetic Stimulation Enables Controlled Opening of Blood-Brain Barrier

    Deep Transcranial Magnetic Stimulation Enables Controlled Opening of Blood-Brain Barrier Potential for

    Read More
  • 1 August, 2016 - ,

    Helmet treating Austin patients suffering from depression

    AUSTIN (KXAN) — Depression hurts millions of Americans, leaving them feeling discouraged, hopeless and even suicidal. While some find healing in drug medications, others don’t respond or can’t

    Read More
  • 12 July, 2016 - ,

    Brainsway USA Announces New Headquarters in the Greater New York Metropolitan Area

    HACKENSACK, N.J., July 12, 2016 (GLOBE NEWSWIRE) — 

    Read More
  • 3 July, 2016 - ,

    Helmet for treating depression being used in Austin

    Danny Pyka, an Austinite who worked for Mercedes-Benz for about 10 years, had been suffering from depression for so long and so severely that he was certain his suicidal thoughts would eventually

    Read More
  • 23 June, 2016 - ,

    Brainsway Insurance Coverage Grows! Now Covered By Tricare

    Brainsway is happy to announce that TRICARE insurance now covers Brainsway’s Deep TMS Therapy. The new coverage gives 9.6 million people access to this non-invasive treatment of major depressive

    Read More
  • 22 June, 2016 - ,

    Brainsway Deep TMS: “A Promising Treatment for Obesity”

    Brainsway Deep TMS: “a Promising Treatment for Obesity” Caused weight loss, a decrease in food craving

    Read More
  • 21 June, 2016 - ,

    Brainsway USA Announces Final Q1 2016 Results With Highest Sales and Revenue Growth in Company’s History

    Brainsway USA Announces Final Q1 2016 Results With Highest Sales and Revenue Growth in Company’s History Company Reports 95 Percent Increase in Revenue from Previous Year Hackensack,

    Read More
  • 7 June, 2016 - ,

    Transcranial Magnetic Brain Stimulation Helps Depression

    Rebeccca had suffered for years from major depression. She had taken antidepressants and undergone pyschotherapy, but nothing helped. Rebecca realized she had treatment resistant depression, but didn’t

    Read More
  • 26 May, 2016 - ,

    Brainsway Clip: Why every psychiatrist should have a Deep TMS device

    Brainsway Clip: Why every psychiatrist should have a Deep TMS device Click here to watch the video

    Read More
  • 25 May, 2016 - ,

    Magnetic Pulses May Ease Depression

    I sat in a chair that looked like it was rejected from the set of the original “Star Trek” series. Ear plugs — brand name “Skull Screws” — were twisted into each ear. A blue felt cap

    Read More
  • 25 May, 2016 - ,

    How a special helmet can help fight depression

    GAITHERSBURG, Md. (WUSA9)– Rebecca had her first bout with depression when she was 16.  In her 60’s now, Rebecca has taken almost every anti-depressant known to mankind. She says

    Read More
  • 24 May, 2016 - ,

    Dr. Sheth presenting his webinar!

    Manish Sheth, M.D., Ph.D., DABPN, is the Program Director of Transcranial Magnetic Stimulation at the Sovereign Health clinic in San Clemente, CA. Dr. Sheth specializes in helping patients with treatment

    Read More
  • 23 May, 2016 - ,

    Your Health Matters: Transcranial Magnetic Stimulation

    Featured on NBC affiliate MKIR: Transcranial Magnetic Stimulation or TMS, is used to stimulate nerve cells in the brain to improve the symptoms of resistant depression. Janet Zappala talks with a TMS

    Read More
  • 18 May, 2016 - ,

    Deep TMS Promising for OCD, ADHD, Other Mental Illnesses

    ATLANTA ― Deep transcranial magnetic stimulation (dTMS), already approved for treatment-resistant depression, is proving beneficial for obsessive compulsive disorder (OCD), adult attention- deficit/hyperactivity

    Read More
  • 10 May, 2016 - ,

    Preliminary Results Show Deep TMS to be Effective & Safe as an Add-On Treatment for Chronic Migraines

    Preliminary Results Show Deep TMS to be Effective & Safe as an Add-On Treatment for Chronic Migraines JERUSALEM – Brainsway® Ltd (TASE:BRIN), the

    Read More
  • 4 May, 2016 - ,

    Corebrain Journal Podcast with Dr. Tendler

    BrainsWay® CMO, Dr. Aron Tendler, was interviewed by Corebrain Journal about Deep TMS and its usage an treatment for depression and other conditions. [Deep] TMS provides some surprisingly

    Read More
  • 26 April, 2016 - ,

    Scibabe Blogger Profiles Brainsway and Deep TMS

    Scibabe stopped by Dr. Martha Koo’s clinic in Manhattan Beach, CA, to discuss Brainsway® and Deep TMS treatments: The overall results from the Brainsway are impressive. Deep TMS is

    Read More
  • 10 April, 2016 - ,

    Medscape: High-Frequency, Deep TMS Offers Novel Approach to OCD

    PHILADELPHIA ― High-frequency deep transcranial magnetic stimulation (TMS) that targets signaling pathways involved in obsessive compulsive disorder (OCD) is showing promise as a novel approach for

    Read More
  • 24 March, 2016 - ,

    Israel’s Medical Pioneers Aim for Global Acclaim

    In a quiet office in an industrial park in Jerusalem, an Israeli woman in a white coat slowly binds a black coil to the surface of a metal dome. She is creating the insides of a helmet that may help

    Read More
  • 14 March, 2016 - ,

    Deep TMS as a Treatment for Depression, and the Link Between ADD and Depression

    Dr. Aron Tendler, CMO of Brainsway®, is interviewed on Deep TMS as a treatment option for depression, as well as the conncetions between depresison and ADD. Listen to the interview here.

    Read More
  • 29 February, 2016 - ,

    Study Finds Brainsway Deep TMS Safe and Effective for the Treatment of ADHD

    Results demonstrate a substantial therapeutic advantage for deep and widespread stimulation using Brainsway’s proprietary ADHD coil over superficial stimulation with a standard figure-8

    Read More
  • 22 February, 2016 - ,

    Deep TMS: How This New Treatment May Help Those With Depression

    If you’re among the more than 350 million people across the globe who 

    Read More
  • 31 December, 2015 - ,

    CGS Medicare healthcare insurance adds Deep TMS coverage in Kentucky and Ohio

    CGS Medicare healthcare insurance has announced that it will offer reimbursement for patients receiving Brainsway® Deep TMS therapy in Ohio and Kentucky. The Deep TMS reimbursement will be valid

    Read More
  • 8 December, 2015 - ,

    Brainsway Opens Mexico market through an Exclusive Distribution Agreement with Moksha

    BrainsWay® Ltd. (TASE: BRIN), a leader in non-invasive brain stimulation, is pleased to announce a new partnership agreement with Moksha, a leader

    Read More
  • 6 December, 2015 - ,

    CBS: Alternative Depression Therapy Available With No Side Effects

    NOTE: This content was created by a third party unaffiliated with Brainsway. While Deep TMS is a well-tolerated treatement, patients sometimes experienece  non-systemic side effects.  The most common

    Read More
  • 8 November, 2015 - ,

    Study Finds Deep TMS Safe and Effective as an Add-On Treatment for Parkinson’s Disease

    JERUSALEM ­– Brainsway® Ltd (TASE:BRIN), the leader in advanced noninvasive treatments for brain disorders, announced the final results of a

    Read More
  • 2 November, 2015 - ,

    Study Finds Brainsway Deep TMS Safe and Beneficial for Geriatric Depression

    According to American Clinics’ Statistics, 44% reached remission and 63% reached a significant response JERUSALEM

    Read More
  • 20 October, 2015 - ,

    Brainsway Enhances Its Clinical Leadership with Appointment of Dr. Aron Tendler as Chief Medical Officer

    Philadelphia, PA.,– Brainsway® Ltd.(TASE: BRIN), a leading company in the development of revolutionary brain disorder treatments, today announced that Dr. Aron Tendler, M.D. will assume the role

    Read More
  • 6 October, 2015 - ,

    Brainsway Partners With U.S Navy to Provide Innovative Deep Transcranial Magnetic Stimulation (Deep TMS) for Depression Treatment

    PHILADELPHIA – Brainsway®, the leader in the development of advanced noninvasive treatments for brain disorders, today announced its partnership with the United States Navy to implement Deep Transcranial

    Read More
  • 16 September, 2015 - ,

    Journal of Affective Disorders Study Finds Deep TMS to Have Acute Antidepressant Effects on TRD Patients

    Wednesday, September 16, 2015 Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis Kedzior, K. K., Gellersen,

    Read More
  • 10 September, 2015 - ,

    Brainsway Expands Management Team with Appointment of Joseph Perekupka as VP of Sales Operations, North America

    Appointment Reinforces Brainsway’s U.S. Presence Har

    Read More
  • 16 August, 2015 - ,

    Brainsway Appoints Avi Posen as VP Global Sales

    Appointment Strengthens Brainsway’s Management and International Activity Brainsway® announced this week that it has appointed Avi Posen to the position of VP Global Sales, effective August

    Read More
  • 16 July, 2015 - ,

    Brainsway Deep TMS covered by Blue Cross Blue Shield North Carolina

    Brainsway® is excited to announce that Transcranial Magnetic Stimulation is now available to Blue Cross Blue Shield North Carolina clients. Coverage for Brainsway’s TMS treatment is being reviewed

    Read More
  • 2 July, 2015 - ,

    Brainsway’s Deep TMS treatment now covered by Humana for severe depression patients.

    Brainsway® Deep TMS treatment now covered by Humana for severe depression patients. Humana is the fourth largest health insurance company in the United States, with approximately 14 million

    Read More
  • 29 June, 2015 - ,

    Brainsway Receives ARTG Approval for Marketing its Deep TMS Treatment for Depression in Australia

    Brainsway to Expand its Activities in Australia, Previously Focused on Research JERUSALEM,

    Read More
  • 2 June, 2015 - ,

    UCSD psychiatrist David Feifel uses Deep TMS to help Depression patient

    Jay Martin, a patient who has struggled with depression for decades, describes Brainsway® Deep TMS as a Godsend, after being treated at UC San Diego’s Department of Psychiatry. Watch a video

    Read More
  • 9 February, 2015 - ,

    World Psychiatry Journal 02/2015: Multicenter double blinded randomized controlled trial results show Brainsway Deep TMS to be efficacious and safe for drug-resistant depression, with a stable effect over 3 months of maintenance treatment.

    A clinically significant improvement was seen even  in highly treatment-resistant patients who did not respond to three or more antidepressant medications in the current episode

    Read More
  • 1 January, 2015 - ,

    Article: Duke study shows magnet therapy can help depression

    View article

    Read More
  • 10 January, 2013 - ,

    BrainsWay Receives FDA Approval

    JERUSALEM, Thursday 10, 2013 Brainsway® Ltd. (TASE: BRIN)  is proud to announce that the U.S. Food and

    Read More
  • Meet BrainsWay® at the International Obsessive Compulsive Disorder (OCD) Foundation Conference 2018
    27-29 July, 2018
    Washington, D.C.

    Meet BrainsWay® at the International Obsessive Compulsive Disorder (OCD) Foundation Conference 2018

    Meet BrainsWay® at the International Obsessive Compulsive Disorder (OCD) Foundation Conference 2018 July 27-29, 2018 Washington,

    Read More